Wai Yuen Tong Medicine Holdings (HKSE:00897) Gross Profit : HK$668 Mil (TTM As of Sep. 2023)

Wai Yuen Tong Medicine Holdings Gross Profit Chart

Wai Yuen Tong Medicine Holdings Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Gross Profit		Get a 7-Day Free Trial					301.53	281.58	445.28	570.39	611.78

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Gross Profit	Get a 7-Day Free Trial															275.21	295.18	268.19	343.59	324.03

Competitive Comparison of Wai Yuen Tong Medicine Holdings's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's Gross Profit falls into.

Wai Yuen Tong Medicine Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Wai Yuen Tong Medicine Holdings's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Wai Yuen Tong Medicine Holdings's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$668 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Wai Yuen Tong Medicine Holdings's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Wai Yuen Tong Medicine Holdings  (HKSE:00897) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Wai Yuen Tong Medicine Holdings had a gross margin of 47.73% for the quarter that ended in Sep. 2023 => Durable competitive advantage

Wai Yuen Tong Medicine Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description